Is a post-marketing study stuck at case collection
Run post-marketing follow-up on consented patients.
Why it costs so much
Post-marketing follow-up runs hospital by hospital: a contract per site, case report forms collected, missing fields chased. That is how the cost of one case accumulates.
And site-based collection breaks the moment the patient leaves that hospital. What happened after the switch is invisible to that structure.
Our structure is different
It starts from the patient, not the hospital.
Consented patients
Patients consent directly and request their own records. No per-site contracts.
Prospective patient-reported data
Not only medical records. Patients log medication and symptoms themselves in the app — prospective collection on top of the retrospective record.
A living cohort
When a patient moves hospitals, new records keep arriving under the same person. 610 patients hold records from two or more hospitals.
It goes in this order
Define the product and the follow-up items.
Recruit the target patients on consent.
Medical records and patient-reported data accumulate.
Track the course through question access.
Common questions
- Can this substitute for statutory PMS requirements?
- Whether requirements are met is for you and the regulator to decide. We build the consented follow-up data and the documents on it, and we confirm what it can be used for before contract.
- How many patients on our product does the corpus hold now?
- You can count by product name right now. If it falls short, we recruit users of that product as the criteria.
- What about adverse event reporting obligations?
- Reporting obligations stay with the license holder. We count and excerpt what the records and patient logs contain; the reporting decision and filing follow your procedures.
